Skip to content
Tenfell
Upcoming
Published 26 Sep 2018

Antibody profiling of Plasmodium vivax positive serum samples by quantitative suspension array technology

Medicines and Healthcare products Regulatory Agency · United Kingdom

Key facts

Estimated value
£10,000
Contract starts
01 Nov 2018
Contract ends
30 Mar 2019
Procedure
Open procedure (below threshold)
Buyer type
Central government

Description

The National Institute for Biological Standards and Control (NIBSC) are developing a Reference Reagent for anti-malaria (Plasmodium vivax) human serum. The source material for this Reference Reagent comprises serum from multiple (>30) P. vivax-infected donors. To ensure that the Refence Reagent is fit for purpose, and to inform decisions on the pooling of source material from different donors, we require the antibody reactivity profile of this source plasma to be characterised by quantitative suspension array technology (qSAT). Specifically, we require that total IgG, IgG1, IgG2, IgG3, IgG4, IgM and IgE levels of up to 60 serum samples, to 20 Plasmodium antigens, be measured. NIBSC will supply the serum samples and recombinant Plasmodium antigens.

Additional information: Contract will be published on our Bravo e-procurement portal.

Categories (CPV)

Similar open tenders

About Medicines and Healthcare products Regulatory Agency

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.